Skip to main content
Clinical Trials/CTRI/2022/03/040988
CTRI/2022/03/040988Not yet recruiting未知

AN OBSERVATIONAL CROSS-SECTIONAL STUDY TO EXPLORE THE CONCEPT â??VATALADYA SADATURAâ?? WITH THE HELP OF IMMUNITY MARKER (IgG) IN POST COVID PATIENTS

All India Institute of Ayurveda0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1.Individuals tested negative for RT-PCR after Covid-19 infection.
  • 2.Patients will be taken minimum after One month of completion of 2nd dose vaccine.
  • 3.Patients who are willing to give their consent.

Exclusion Criteria

  • 1.Patients having history of dementia and Alzheimerâ??s.
  • 2.Patients having illness which hamper the immunity of the subjects will be excluded.
  • 3.Patients with immune deficiency (AIDS,) diseases and hyperimmune, (rheumatoid arthritis, Crohnâ??s disease, SLE, Multiple sclerosis, type1 diabetics mellitus, psoriasis, Guillain barre syndrome and other allergic reaction).

Investigators

Similar Trials